Irisin Prevents Disuse-Induced Osteocyte Apoptosis
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Previous results showed that intermittently administered irisin improves bone mass in normal mice and prevents the development of disuse-induced osteoporosis and muscular atrophy in hindlimb-suspended mice, a murine model able to mimic the absence of mechanical loading. A recent study showed that irisin increases survival of osteocytes acting through integrin αV/β5 receptors. To better understand the action of irisin on these cells, we investigated the downstream signaling cascades in osteocyte-like cells (MLO-Y4) treated with recombinant irisin (rec-irisin) in vitro and we analyzed survival of osteocytes and caspase activation in cortical bone of osteoporotic mice treated with rec-irisin in vivo. Our results revealed that rec-irisin activated the MAP kinases Erk1 and Erk2 and increased the expression of the transcription factor Atf4 (2.5-fold, p < .05) through an Erk-dependent pathway in osteocytes. Some key genes expressed by MLO-Y4 cells were modulated by long-term irisin treatment, either continuously administered or given with intermittent short pulses. Interestingly, Sost mRNA was severely downregulated only upon intermittent irisin administration (10-fold, p < .001). Furthermore, rec-irisin upregulated Tfam mRNA (fourfold, p < .05) and Bcl2/Bax ratio (twofold, p < .05) in MLO-Y4 cells. By detecting caspase-9 and caspase-3, we also found that rec-irisin inhibited apoptosis induced by hydrogen peroxide and dexamethasone, respectively. In cortical bone of unloading C57BL6 mice treated with vehicle (unload-veh), irisin prevented disuse-induced reduction of viable osteocytes (+30% versus unload-veh, p < .05) and increase of empty lacunae (+110% versus unload-veh, p < .05), as well as caspase-9 (threefold, p < .05) and caspase-3 (twofold, p < .05) activations. Our findings revealed underlying mechanisms of irisin action on osteocytes, which increases their functions and exerts anti-apoptotic effects, confirming that mechanosensor cells of bone are sensitive to the exercise-mimetic myokine irisin. © 2019 American Society for Bone and Mineral Research. Abstract Schematic representation of irisin's action on osteocytes to activate ERK phosphorylation, which in turn stimulates the increase of Atf4 mRNA levels. A recent study showed that irisin increases survival of osteocytes acting through integrin αV/β5 receptors. To elucidate the action of irisin on osteocytes, we investigated the downstream signaling cascades in MLO-Y4 cells treated with recombinant irisin (rec-irisin). We found that rec-irisin activated the MAP kinases Erk1 and Erk2 and increased the expression of the transcription factor Atf4 through an Erk-dependent pathway in osteocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287 · cited 7×
“Contrastingly, mRNA levels of Dkk1, the other antagonist of the Wnt/beta-catenin signaling pathway, were downregulated by rec-irisin when continuously administered (1.5-fold, p .05) (Fig.”
BackgroundInfluentialWeinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 1×
“ment and sex steroid deficiency have been shown to increase osteocyte apoptosis in animals and humans.((2,3)) Moreover, the osteocyte death observed in the murine model of estrogen deficiency, temporally and spatially coupled to increased bone resorption, has been shown to resemble that observed in a murine model of d…”
Mitochondrial transcription factor A is necessary for mtDNA maintance and embryogenesis in mice
Larsson, N.-G., Wang, J., Wilhelmsson, H., Oldfors, A., Rustin, P., Lewandoski, M., Barsh, G. S., & Clayton, D. A. (1998) · Nature Genetics · doi:10.1038/ng0398-231 · Cited by 1,594
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890 · cited 1×
“Conversely, intermittent administration of parathyroid hormone (PTH) or estrogen replacement therapy prevents osteocyte apoptosis, suggesting that the anabolic action of these treatments is also exerted by preserving osteocyte survival.((5,6)) Physical activity could also promote osteocyte viability independently from…”
BackgroundIrisin Mediates Effects on Bone and Fat via αV Integrin Receptors
Kim, H., Wrann, C. D., Jedrychowski, M., Vidoni, S., Kitase, Y., Nagano, K., Zhou, C., Chou, J., Parkman, V.-J. A., Novick, S. J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.025 · Cited by 638
Cherian, P. P., Siller-Jackson, A. J., Gu, S., Wang, X., Bonewald, L. F., Sprague, E., & Jiang, J. X. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-10-0912 · Cited by 481
β-aminoisobutyric Acid, l-BAIBA, Is a Muscle-Derived Osteocyte Survival Factor
Kitase, Y., Vallejo, J. A., Gutheil, W., Vemula, H., Jähn, K., Yi, J., Zhou, J., Brotto, M., & Bonewald, L. F. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.041 · Cited by 219 · cited 1×
“acid (BAIBA) protects osteocytes against ROS-induced apoptosis and prevents both bone and muscle loss.((7)) Noteworthy, it has”
Background
Cited by
Sarcopenia, osteoporosis and frailty
Gielen, E., Dupont, J., Dejaeger, M., & Laurent, M. R. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155638 · Cited by 258
Progress and Challenges in the Biology of FNDC5 and Irisin
Maak, S., Norheim, F., Drevon, C. A., & Erickson, H. P. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab003 · Cited by 247
“A number of subsequent studies applying irisin to cell cultures also supported a direct interaction with bone cells (117-119).”
BackgroundResultTargeting strategies for bone diseases: signaling pathways and clinical studies
Xu, H., Wang, W., Liu, X., Huang, W., Zhu, C., Xu, Y., Yang, H., Bai, J., & Geng, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01467-8 · Cited by 162
“Of note, irisin, an endogenous mediator secreted by the muscle in response to physical activities, has been found to prevent disuse-induced osteocyte apoptosis and upregulate sclerostin expression by targeting its main receptor integrin α5β5 on osteocytes through the ERK/ATF4 signaling pathway.(146,147) In particular,…”
BackgroundIrisin, an exercise-induced bioactive peptide beneficial for health promotion during aging process
Zhang, H., Wu, X., Liang, J., Kirberger, M., & Chen, N. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101680 · Cited by 88
Irisin promotes fracture healing by improving osteogenesis and angiogenesis
Kan, T., He, Z., Du, J., Xu, M., Cui, J., Han, X., Tong, D., Li, H., Yan, M., & Yu, Z. (2022) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2022.07.006 · Cited by 60
“However, other studies have shown that intraperitoneal administration has a strong regulatory effect on bone tissues in mice [14,59].”
BackgroundZhao, S., Ge, C., Li, Y., Chang, L., Dan, Z., Tu, Y., Deng, L., Kang, H., & Li, C. (2022) · Journal of Biological Engineering · doi:10.1186/s13036-022-00314-8 · Cited by 11
“Several reports showed that osteocyte death by apoptosis was implicated in pathological conditions that correlated with bone loss [15, 16].”
Background
Metadata
- Authors
- Storlino, G., Colaianni, G., Sanesi, L., Lippo, L., Brunetti, G., Errede, M., Colucci, S., Passeri, G., & Grano, M.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-12-11
- Volume
- 35
- Issue
- 4
- Pages
- 766-775
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2996370310
- Cited by
- 125
- References
- 7
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.